You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

car t-cell therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Gut microbiome analysis
  • Bologna, Italy
    Institute Of Hematology "Seràgnoli"
Feb 10, 2023

B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B Lineage Lymphoblastic Lymphoma
  • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
  • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jan 25, 2023

Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

Not yet recruiting
  • Relapsed/Refractory Large B Cell Lymphoma
  • ALLO-647
  • +3 more
  • (no location specified)
Feb 6, 2023

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti-siglec-6 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 2, 2022

T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • Shanghai, China
    Xianmin General Song
Aug 29, 2022

Lymphoma, Large B-Cell, Diffuse Trial (Cyclophosphamide, TLI, Fludarabine)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • (no location specified)
Aug 18, 2023

Langerhans Cell Histiocytosis Trial in Beijing (CD207 CAR-T cells)

Not yet recruiting
  • Langerhans Cell Histiocytosis
  • CD207 CAR-T cells
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jul 25, 2022

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

Not yet recruiting
  • Lymphoma, B-Cell
  • +7 more
  • Adaptive Bridging Radiation Therapy (ABRT)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2023

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

Recruiting
  • Lupus Nephritis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Denver, Colorado
  • +1 more
Jul 7, 2023

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous

Not yet recruiting
  • Recurrent Glioblastoma
  • Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 10, 2022

DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 19, 2023

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

    Not yet recruiting
    • SLE (Systemic Lupus)
    • CAR T-cell therapy
    • Bangkok, Please Select, Thailand
      King Chulalongkorn Memorial Hospital
    Nov 23, 2023

    Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

    Not yet recruiting
    • Extramedullary Myeloma
    • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Dec 18, 2022

    Febrile Neutropenia Trial in Charleston (IDION iTempShield)

    Not yet recruiting
    • Febrile Neutropenia
    • IDION iTempShield
    • Charleston, South Carolina
      Medical University of South Carolina
    Oct 8, 2022

    Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

    Recruiting
    • CAR-T Therapy Complications
      • Bologna, Italy
        IRCC, University Hospital of Bologna
      Mar 18, 2022

      CART Therapy Trial in Madrid

      Completed
      • CART Therapy
        • Madrid, Spain
          Angel Cedillo
        May 26, 2022

        Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • PK Blood Collection
        • +2 more
        • (no location specified)
        Nov 1, 2022

        Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

        Not yet recruiting
        • Kidney Transplant
        • +2 more
        • Boston, Massachusetts
        • +2 more
        Sep 20, 2023

        Leukemia Trial in Aurora (BioIntelliSense BioButton Rechargable, Memora Health two-way patient engagement platform provided by

        Recruiting
        • Leukemia
        • BioIntelliSense BioButton Rechargable
        • Memora Health two-way patient engagement platform provided by RC
        • Aurora, Colorado
          University of Colorado Hospital
        Apr 20, 2023

        Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

        Not yet recruiting
        • Recurrent Diffuse Large B-Cell Lymphoma
        • Refractory Diffuse Large B-Cell Lymphoma
        • Biospecimen Collection
        • +6 more
        • Duarte, California
          City of Hope Medical Center
        Mar 24, 2023